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The erythrocyte Rh antigens contain an M, = 32,000 
integral  protein  which is thought  to  contribute  in  some 
way  to  the  organization of surrounding  phospholipid. 
To  search  for  possible  fatty  acid  acylation  of  the Rh 
polypeptide, intact human erythrocytes were incu- 
bated with [‘H]palmitic acid prior to preparation of 
membranes  and  sodium  dodecyl  sulfate-polyacryl- 
amide gel electrophoresis and fluorography. Several 
membrane proteins were labeled, but  none  corre- 
sponded  to  the  glycophorins  or  membrane  proteins 1- 
8. An M, = 32,000 band was prominently  labeled  on 
Rh (D)-negative and -positive erythrocytes  and  could 
be  precipitated from  the latter with anti-D. No similar 
protein was labeled  on  membranes  from RhmM eryth- 
rocytes, a  rare  phenotype  lacking Rh antigens.  Label- 
ing of  the Rh polypeptide  most likely represents  pal- 
mitic  acid  acylation  through  thioester linkages. The 3H 
label was not  extracted with chloroform/methanol,  but 
was quantitatively  eluted with hydroxylamine  and  co- 
chromatographed with palmitohydroxamate  and free 
palmitate  by  thin  layer  chromatography.  The fatty acid 
acylations occurred  independent  of  protein synthesis 
and were completely  reversed by chase with unlabeled 
palmitate.  It is concluded  that  the Rh polypeptide is 
fatty acid-acylated,  being  a major substrate  of  an acy- 
lation-deacylation  mechanism  associated with the 
erythrocyte  membrane. 
The human  erythrocyte Rh antigens  are of great clinical 
importance, but have only recently become understood on a 
molecular level (see reviews,  Refs. 1 and 2). An Mr = 32,000 
integral protein (“Rh polypeptide”) is the membrane site of 
the  Rh antigens (3,4). The  Rh polypeptide is unusual in  that 
it contains no detectable carbohydrate (5) and  is associated 
with the membrane skeleton (6-8). The  Rh polypeptide has 
recently been purified (9, 10); the NH2-terminal  amino acid 
sequence has been determined (11, 12); internal polymor- 
phisms have been identified (12-14). Nevertheless, a physio- 
logical role for the  Rh antigen  and polypeptide have not  yet 
been identified. 
Covalent attachment of lipid could explain several puzzling 
* This work  was supported by Grant HL33991 from the National 
Institutes of Health. The costs of publication of this article were 
defrayed in part by the payment of page charges. This article  must 
therefore be hereby marked “aduertisement” in accordance with 18 
U.S.C. Section 1734  solely to indicate this fact. 
$ Participant  in  the first  Erasmus-Johns  Hopkins Medical Student 
Exchange. Present address: Erasmus University School of Medicine, 
Rotterdam, The Netherlands. 
$ Recipient of an Established Investigator Award from the Amer- 
ican Heart Association. To whom correspondence and reprint re- 
quests should be addressed. 
characteristics of the Rh polypeptide. Efforts to solubilize the 
Rh polypeptide during purification were impeded by an ex- 
treme degree of hydrophobicity (9, 10). Several observations 
indicate that the Rh antigen may be a complex of lipid 
specifically associated with the Rh polypeptide (15-18), and 
rare individuals lacking all  Rh  antigens (Rh,,ll (19)) express 
secondary defects (20,21) resulting from abnormal membrane 
bilayer phospholipid organization (22). Recent work has dem- 
onstrated  that  fatty acid acylation of some membrane proteins 
is a specific biological event (see review,  Ref. 23), and certain 
membrane proteins of embryonic avian erythrocytes were 
found to undergo post-translational  fatty acid acylation (24). 
This report  demonstrates palmitic acid acylation of the Rh 
polypeptide and partially characterizes the mechanism by 
which this  post-translational  event occurs. 
EXPERIMENTAL  PROCEDURES 
~ H J P ~ ~ i ~ i c  Acid Labeling-The procedure was derived from a 
published method (24). Freshly drawn human erythrocytes were 
washed free of other cells and suspended 1 : lO  in 2 ml of minimum 
essential medium (Gibcoj containing 5 mM pyruvate, 0.1 mM L-amino 
acids, pH 7.4, to which 2 mCi  of [9, 10 3H]palmitic acid (29 Ci/mmol, 
Du Pont-New England Nuclear) was  added. The cells were shaken 
overnight a t  37 “C, then washed in chilled 0.15 M NaC1, 10 mM 
NaP04, 1 mM NaEDTA, pH 7.4. Membranes were prepared (25) and 
electrophoresed into 14% SDS‘-PAGE gels (26). The gels  were Coo- 
massie-stained, soaked with enhancing solution (Amplify, Amer- 
sham), and exposed to autoradiographic film (Kodak, XARj for up 
to 1 week. Immunoprecipitations were performed basically as de- 
scribed (10) with Rh (D) immune globulin (Cutter)  or nonimmune 
globulin added to  the tubes during the j3H]palmitic acid labeling. 
Characterization of Acyhtions-Membranes prepared from [‘HI 
palmitic acid-labeled erythrocytes were depleted of noncovalently 
associated lipid by repeated extractions with CHC13/CH~OH/Hz0 
(2:2:1.8) (27), and  the delipidated membranes were incubated in 0.5 
M hydroxylamine, pH 9, as described (28) prior to SDS-PAGE. In 
other experiments, Rh ~ l ~ p t i d e s  immunoprecipitated from [3H] 
palmitic acid-labeled erythrocyte membranes were repeatedly ex- 
tracted with CHC4/CHaOH/Hz0, and approximately 45% of the 
immunoprecipita~d 3H was thereby extracted (40% removed in first, 
5% in second plus third washings). The  Rh polypeptide was subse- 
quently incubated in 1 M hydroxylamine at pH  7 or 9 for 1 h at 22 “C 
which released >95% of the remaining 3H. The released lipid was 
partitioned into CHCla, spotted onto Silica Gel 60 HPTLC plates 
(Merck), and chromatographed with toluene/methanol/acetic acid 
(90101) basically as described (28). 
RESULTS 
Intact huEan erythrocytes were incubated with 13H]pal- 
mitic acid, and  the membranes were analyzed by SDS-PAGE 
and fluorography (Fig. I). Approximately six major bands 
were labeled with [3H]palmitic acid, but none corresponded 
to glycophorins or  bands 1-8 (29). A variable amount of the 
’ The abbreviations used are: SDS, sodium dodecyl sulfate; PAGE, 
polyacrylamide gel electrophoresis. 
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FIG. 1. ['HIPalmitic  acid  labeling of the  Rh  polypeptide  and 
other erythrocyte membrane proteins. Erythrocytes from the 
following individuals were labeled with ['Hlpalmitic acid: an  Rh(D)- 
negative individual, probable cdelcde genotype (lanes I ,  2,5, and 7); 
an Rh(D)-positive individual, CDelcDE (lanes 3, 6, and 8); and  an 
Rhmd individual (lane 4 ) .  SDS-PAGE gels of membranes were stained 
with Coomassie Blue (lane I )  or visualized by fluorography (lanes 2- 
4) .  Polypeptides precipitated from [3H]palmitic acid-labeled eryth- 
rocytes with Rh(D) immune globulin (lanes 5 and 6) or nonimmune 
globulin (lanes 7 and 8) were analyzed by fluorography. Proteins  are 
identified at  the left margin (29). 
3H label was associated with  unidentified  material of M,  > 
300,000 which remained at  the origin of all  separating gels. A 
protein of approximately M, = 32,000 appeared above band 7 
and was consistently heavily labeled, constituting 20-30%  of 
the  total 3H label associated with membrane proteins between 
M,= 10,000 and M ,  = 300,000 when assessed by densitometry. 
The M ,  = 32,000 band is the  Rh polypeptide. A core Rh 
polypeptide exists  in  membranes of both  Rh(D)-negative and 
-positive erythrocytes, although the Rh polypeptide in the 
former lacks the surface  D epitope (12). The  Rh polypeptide 
is presumably missing from Rh,,ll erythrocytes and severely 
diminished in Rh,& erythrocytes, rare phenotypes lacking Rh 
D, C/c, and  E/e antigens. The M, = 32,000 band was labeled 
equivalently with [3H]palmitic acid on  membranes from 
Rh(D)-negative and -positive erythrocytes, but  the band was 
labeled extremely weakly on  membranes from Rh,& eryth- 
rocytes (Fig. 1, lanes 2-4). The M,  = 32,000 band was precip- 
itated with Rh(D) immune globulin only from the Rh(D)- 
positive erythrocytes, but was not precipitated  with  nonim- 
mune globulin (lanes 5-8). Similar bands  (not shown) were 
immunoprecipitated from Rh(D)-positive  erythrocytes (CDe/ 
cDE) with monoclonal antibodies specific for the  Rh D, c, 
and E  antigens (gift of Dr. J.-P. Cartron, Centre National  de 
Transfusion  Sanguine Institut,  INSERM U76, Paris). 
The [3H]palmitic acid labeling is apparently through  thioes- 
ter linkages. The 3H label associated with membrane  proteins 
was found to survive extraction with chloroform/methanol, 
but was trans-esterified with hydroxylamine (Fig. 2, left 
panel). Rh polypeptide immunoprecipitated from [3H]pal- 
mitic acid-labeled erythrocytes was repeatedly washed with 
chloroform/methanol to elute all noncovalently associated 
fatty acid. The remaining 3H label (approximately 55% of 
original) was quantitatively  eluted with hydroxylamine at  pH 
7 or pH 9, and the eluates were analyzed by thin layer 
chromatography and compared to  standards (Fig. 2, center 
and right panels). The  pH 7 and  pH 9 eluates co-chromato- 
graphed with standard palmitohydroxamate and free palmitic 
acid, respectively, indicating that  the 3H label represented 
esterified fatty acid rather  than incorporation of a metabolic 
product derived from the [3H]palmitic acid (30,31). 
Protein synthesis is not required for [3H]palmitic acid 
labeling. Reticulocytes still actively synthesize proteins, while 
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FIG. 2. ['HJPalmitic acid labeling is most likely through 
thioester  linkages.  The left panel is an SDS-PAGE fluorograph of 
untreated membranes (lane 1 ), CHC13/CH30H/H20-extracted mem- 
branes before (lane 2) and after (lane 3) hydroxylamine incubation. 
Exposure of lanes 2 and 3 was longer due to lower protein loadings. 
No qualitative differences of the membrane proteins were noted on 
Coomassie-stained SDS-PAGE gels. The center and right paneels are 
thin layer chromatography analyses of fatty acid released from Rh 
polypeptide by hydroxylamine at pH 7 and 9. Arrows identify the 
locations of standard palmitohydroxamate, RF = 0.26 (prepared  as 
described, Ref. 36), and free palmitic acid, RF = 0.42, run  on the same 
plate. 
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FIG. 3. Protein synthesis is not required for ['Hlpalmitic 
acid  labeling of the R h  polypeptide. Blood  was obtained from a 
normal individual with 0.9% circulating reticulocytes and a  patient 
with sickle cell disease and 23% reticulocytes. Erythrocytes were 
labeled with [3H]palmitic acid, and  the SDS-PAGE gel  of the mem- 
branes was analyzed by fluorography: normal, lane I ;  and high retic- 
ulocytes, lane 2. The effect of protein synthesis inhibition was eval- 
uated by incubating normal erythrocytes with 25 pCi  of a mixture of 
I4C-~-amino-acids (lanes 3 and 4 )  (10 mCi/mmol, Du Pont-New 
England Nuclear) or [3H]palmitic acid (lanes 5 and 6 )  without (lanes 
3 and 5 )  or with 50 p~ emetine hydrochloride (lanes 4 and 6) (Sigma). 
The SDS-PAGE gel  of the membranes was visualized by fluorography. 
mature  erythrocytes have little  or no  protein  synthesis. [3H] 
Palmitic acid labelings were compared between peripheral 
blood from an individual with <1% circulating reticulocytes 
and  another with 23% circulating reticulocytes (Fig. 3, lanes 
1 and 2). Some differences in labeling other  bands were noted, 
but  the overall appearance of the  Rh polypeptide was quan- 
titatively and qualitatively very similar. Erythrocytes sedi- 
mented in dextran to eliminate all reticulocytes also had a 
similar labeling pattern  (not shown). Incorporation of I 4 C -  
amino-acids demonstrated that a  small degree of membrane 
protein  synthesis  persists in circulating erythrocytes, but  not 
in polypeptides of M ,  = 32,000 (Fig. 3, lane 3). Protein 
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synthesis was further reduced to -30% by the addition of 
emetine (lane 4 ) ;  however, [3H]palmitic acid labeling was not 
affected (lanes 5 and 6 ) .  
The association of [3H]palmitic acid with  erythrocyte mem- 
brane proteins is a  continuous process which is fully reversi- 
ble. [3H]Palmitic acid labeling of the Rh polypeptide and 
other membrane proteins was detectable after 90 min of 
incubation and proceeded continuously thereafter when fol- 
lowed for 24 h (Fig. 4, left panel). When the labeled erythro- 
cytes were washed and subsequently incubated  in an excess 
of unlabeled palmitic acid, the esterification process was 
completely reversed (light panel). A significant decline in the 
membrane protein-associated [3H]palmitic acid was observed 
after only 1 h of chase, and virtually all [3H]palmitic acid was 
removed after 9 h. It  is likely that  this represents exchange 
of the esterified [3H]palmitic acid with unlabeled fatty acid, 
suggesting that  an acylation-deacylation process is continu- 
ously ongoing for the  Rh polypeptide and a few other mem- 
brane proteins. The  apparent turnover of the 3H label does 
not represent degradation of the Rh(D) antigen or other 
membrane proteins, since Rh(D) immunoreactivity is not 
reduced after incubation and the Coomassie-stained SDS- 
PAGE gel from which the fluorograph was prepared  demon- 
strated no  detectable degradation of any membrane  proteins 
(not shown), 
DISCUSSION 
The Rh polypeptide constitutes only 0.5% of the total 
erythrocyte membrane protein (10, 12), but  it is prominently 
acylated, accounting for 20-30% of the  total [3H]palmitic acid 
linked to membrane proteins in these studies. Fatty acid 
acylation has been recognized for certain peripheral mem- 
brane proteins (32) and on the cytoplasmic domains of certain 
integral membrane proteins  in nucleated cells (33), but  the 
Rh polypeptide is an integral  protein largely restricted to  the 
lipid bilayer of erythrocytes (10). It  cannot be determined 
from these  studies if the  site of the  fatty acid acylation of the 
Rh polypeptide is cytoplasmic, between the leaflets of the 
bilayer, or on extracellular domains. Compositional studies 
may permit  determination of the number of fatty acids cova- 
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FIG. 4. [3H]Palmitic  acid  labeling of erythrocyte membrane 
proteins is continuous  and reversible. Erythrocytes were labeled 
with [3H]palmitic acid for various  intervals (lane 1 = 0.5 h, lane 2 = 
1.5 h, lane 3 = 4.5 h, lane 4 = 12 h, and lane 5 = 24 h). The SDS- 
PAGE gel of the membranes was visualized by fluorography. In a 
separate experiment, erythrocytes were labeled with [3H]palmitic acid 
for 5 h, washed  free of unadsorbed fatty acid,  resuspended in fresh 
minimal essential medium containing 50 pg/ml unlabeled palmitic 
acid  and  incubated  for  various intervals ( l a n e  5 = 0 h, lane 7 = 1 h, 
lane 8 = 3 h, lane 9 = 9 h, and lane 10 = 19 h). Exposure of the 
fluorograph of lanes 6-10 was  twice as long as that of lanes 1-5. 
lently attached  to each core Rh polypeptide. The exuberance 
of the labeling is consistent with multiple acylations, and it 
has been estimated that each Rh polypeptide contains at  least 
3-4 cysteine residues (9,lO). 
Covalent attachment of lipid to  certain eukaryotic  proteins 
has emerged as  an area of intense investigation, but the overall 
biological importance of these modifications is  not well under- 
stood (see review, Ref. 23). Likewise, the biological impor- 
tance of abundant  fatty acid acylation of the  Rh polypeptide 
is not obvious, although  certain clues may have been uncov- 
ered. The  Rh polypeptide probably requires specific flanking 
phospholipid in order to  attain  the proper conformation on 
the membrane surface needed for immunogenicity. Early stud- 
ies demonstrated the requirement of phospholipid for the 
immunoreactivity of the  Rh(D) antigen, since extraction of 
phospholipid with alcohol resulted in the disappearance of 
the  Rh immunoreactivity which was restored by addition of 
exogenous phospholipid (15). Rh immunoreactivity is also 
destroyed by certain phospholipases (16, 17) and can be 
modulated by enrichment or depletion of membrane choles- 
terol (18). The overall amino acid composition of the Rh 
polypeptide includes approximately 50% nonpolar and aro- 
matic residues (9, lo), which is similar to the anion and 
glucose transporters  and  other bilayer spanning polypeptides. 
Nevertheless, the fatty acid acylation appears to be very 
specific, since  these other integral proteins failed to label with 
the methods employed here. 
It is interesting that a single mutation leading to total  loss 
of expression of all the Rh antigens (Rh,,d can produce 
abnormal organization of the phospholipid bilayer (22) and 
abnormal  function of membrane transporters which are em- 
bedded within the bilayer (20,21). Recent work has identified 
an ATP-dependent membrane enzyme for the maintenance 
of phospholipid asymmetry (34), and  an M, - 31,000 mem- 
brane component has been implicated as a  participant (35). 
Whether  the  Rh polypeptide plays a role in the active distri- 
bution of phospholipid between the leaflets of the bilayer or 
a passive role in  maintaining the bilayer is uncertain. The 
presence of covalently attached fatty acid side chains may 
provide the hydrophobic points needed for structurally im- 
portant protein-phospholipid associations to occur and may 
be the mechanism through which the  Rh polypeptide influ- 
ences phospholipid bilayer organization. 
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